Very Low Density Lipoprotein (VLDL) Protein

Produktnummer ABIN934802

Produktdetails

Target: Very Low Density Lipoprotein (VLDL)

Protein-Typ: Native

Spezies: Human

Quelle: Human

Produktmerkmale: Purified native HumanVLDL protein
Contaminants: Essentially free of other plasma lipoproteins as determined by electrophoresis using a SPIFE Vis Cholesterol gel kit for lipids and Coomassie Blue for proteins.
Protein Source: Human plasma

Reinheit: > 95 % pure

Anwendungsinformationen

Applikationshinweise: Each Investigator should determine their own optimal working dilution for specific applications.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: Liquid in 150 mM NaCl, pH 7.4, and 0.01 % EDTA

Vorsichtsmaßnahmen: Donor samples were tested and found to be negative for HBsAg, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2. Nonetheless caution should be used when handling this material as there is a margin of error in all tests.

Handhabung: Keep away from light.

Lagerung: 4 °C

Informationen zur Lagerung: Store at 4 °C.

Antigendetails

Target: Very Low Density Lipoprotein (VLDL)

Andere Bezeichnung: VLDL (VLDL Produkte)

Hintergrund: Very-low-density lipoprotein (VLDL) is a type of lipoprotein made by the liver. VLDL is one of the five major groups of lipoproteins (chylomicrons, VLDL, low-density lipoprotein, intermediate-density lipoprotein, high-density lipoprotein) that enable fats and cholesterol to move within the water-based solution of the bloodstream. VLDL is assembled in the liver from triglycerides, cholesterol, and apolipoproteins. VLDL is converted in the bloodstream to low-density lipoprotein (LDL). VLDL particles have a diameter of 30-80 nm. VLDL transports endogenous products, whereas chylomicrons transport exogenous (dietary) products.
Description: Human plasma.
Alternative Names: VLD Lipoprotein protein, Very Low Density Lipoprotein protein, Apolipoprotein E protein, APO E protein, Apo-E protein

Molekulargewicht: 10-80,000 kDa